Written | 2014-06 | Jessy Hasna, Nazim Benzerdjeb, Malika Faouzi, Anne-Sophie Ay, Philippe Kischel, Frédéric Hague, Henri Sevestre, Ahmed Ahidouch, Halima Ouadid-Ahidouch |
University of Picardie Jules Verne, UFR Sciences, EA 4667, Laboratory of Cell, Molecular Physiology, SFR CAP-SANTE (FED 4231), Amiens, France (JH, NB, MF, ASA, PK, FH, HS, AA, HOA); University of Picardie Jules Verne, Amiens University Hospital, Department of Pathology, Tumor Bank of Picardie, Amiens, France (NB, HS); Department of Biology, Faculty of Sciences, University Ibn Zohr, Agadir, Morocco (AA) |
Identity |
Alias_names | TMEM142C |
transmembrane protein 142C | |
Alias_symbol (synonym) | MGC13024 |
Other alias | |
HGNC (Hugo) | ORAI3 |
LocusID (NCBI) | 93129 |
Atlas_Id | 51589 |
Location | 16p11.2 [Link to chromosome band 16p11] |
Location_base_pair | Starts at 30949084 and ends at 30954938 bp from pter ( according to hg19-Feb_2009) [Mapping ORAI3.png] |
Fusion genes (updated 2017) | Data from Atlas, Mitelman, Cosmic Fusion, Fusion Cancer, TCGA fusion databases with official HUGO symbols (see references in chromosomal bands) |
DPP9 (19p13.3) / ORAI3 (16p11.2) |
Note | ORAI3 is a member of the ORAI family proteins discovered in 2006 as the essential pore-forming components of the low-conductance, highly Ca2+-selective CRAC channels whose activation is dependent on depletion of the endoplasmic reticulum Ca2+ stores (Feske et al., 2006; Vig et al., 2006; Zhang et al., 2006). In Greek mythology, the ORAI are the keepers of the gates of heaven: Eunomia (Order or Harmony), Dike (Justice) and Eirene (Peace). |
DNA/RNA |
Description | ORAI3 is encoded by the gene TMEM142C (HUGO Gene Nomenclature Committee). The ORAI3 gene is located on chromosome 16 in the p11.2. |
Transcription | Size of ORAI3 transcript: 2.2 kb; NCBI ORAI3 mRNA model: NM_152288. All three ORAI isoforms are widely expressed at the mRNA level and can be incorporated into the plasma membrane when ectopically expressed. Broad expression of ORAI3 transcripts has been shown by Northern blot analysis: ORAI3 transcripts are expressed in heart, brain, kidney, thymus, lung, spleen, skeletal muscle, small intestine, as well as in primary aortic endothelial cells and bone marrow derived mast cells (Gwack et al., 2007). ORAI3 appears to be the only family member that is strongly expressed at the RNA level in brain. (ORAI2 transcripts are prominent in kidney, lung, and spleen (Gwack et al., 2007)). Transcripts expression |
Protein |
![]() | |
Schematic representation of ORAI protein structure and organization. Domains of human ORAI1, 2 and 3. P: proline-rich region, R: arginin-rich region, R/K: arginine-lysine-rich region, TM: transmembrane domain, CC: coiled-coil domain (Derler et al., 2012). | |
Description | Description of the protein sequence. Molecular weight: 31499 Da. Sequence length: 295 amino acids. ORAI3 is a plasma membrane protein containing four transmembrane domains with intracellular N- and C-termini. ORAI3 contains a binding domain for calmodulin in its N-terminus, and a coiled-coil domain for protein interaction in its C-terminus. Examination of the overall protein sequence of ORAI3 reveals high percentage of homology with the family members: 63.2% with ORAI1 and 66.4% with ORAI2 (60.3% between ORAI1 and ORAI2). These homology percentages increase when the comparison concerns the transmembrane domains: 93.8% with both ORAI1 and ORAI2, (92.5% between ORAI1 and ORAI2) (Feske et al., 2006; Hewavitharana et al., 2007). The pore-forming transmembrane domains of all three ORAI proteins show a high degree (~82%) of conservation. The amino acid sequence of ORAI3 shows marked differences from its isoforms, particularly in the regions outside of the essential pore-forming domains, which might explain its unique properties and the differences with other isoforms in the modes of regulation and modulation from its isoforms (Shuttleworth, 2012). The sequence identities between ORAI3 and ORAI1 in the cytosolic N- and C-termini are 34% and 46%, respectively, and is 21% in the extracellular loop between transmembrane domains 3 and 4 (Shuttleworth, 2012). The N-terminus of ORAI3 comprises ~65 amino acids and has no clusters of prolines and arginines seen in ORAI1 (N-terminus domain containing ~90 amino acids and rich in clusters of prolines and arginines) (Takahashi et al., 2007; Frischauf et al., 2008). ORAI3 has a second extracellular loop linking transmembrane domains 3 and 4 which is longer than that of ORAI1 and ORAI2 (~72 amino acids in ORAI3 compared to only 38 amino acids in ORAI1). ORAI3 has a cluster of 22 positively charged amino acid residues immediately prior to the first transmembrane region which is fully conserved among all three ORAI channels (H44-R66 in ORAI3 and H69-R91 in ORAI1), and has three conserved glutamates located at the C-terminus to which is attributed the fast Ca2+-dependent inactivation of ORAI3 (Lee et al., 2009). The ORAI3 N-terminus appears critical for switching a store-operated channel to an exclusively arachidonate regulated channel (Thompson et al., 2010). The residues E81 and E165 in the transmembrane domains 1 and 3, and E85, D87 and E89 in the extracellular 1-2 loop are critical determinants of a high Ca2+ selectivity. Other studies using a cysteine-scanning mutagenesis approach in ORAI3 revealed that Ca2+ selectivity was exclusively determined by the E81 residue alone (McNally et al., 2009). Replacing the N-terminal cytosolic domain of ORAI3 with the corresponding domain of ORAI1 doubles the magnitude of the measured store-operated Ca2+ currents, whilst the reverse exchange virtually eliminates all currents. N-terminal deletion experiments narrow the critical region essential for the activation of ORAI3 to amino acids 42-62 (Lis et al., 2010). The appearance of significant store-operated currents dependes on a single specific lysine residue K60 in ORAI3, the conservation of this residue in ORAI1 and ORAI3 cannot explain the differences in the magnitude of store-operated Ca2+ currents between these two ORAI family members. N-terminal deletions of residues between W51 and Y55 significantly increase store-operated ORAI3-dependent currents (Bergsmann et al., 2011). The only sequence difference between ORAI1 and ORAI3 in this region is the substitution of a lysine in ORAI1 for an arginine at position 53 in ORAI3. ORAI3 lacks C195, a reactive cysteine present in ORAI1 that serve as a detection system primarily for changes in the extracellular oxidative environment, and contains two additional cysteines within the extracellular loop between TM3 and TM4. The absence of C195 in ORAI3 makes it resistant to H2O2-inactivation, since pre-incubation with H2O2 of ORAI1/STIM1 expressing cells (HEK; T cells) inhibits activation of ORAI1, but not of ORAI3, and reinsertion of C195 within ORAI3 renders ORAI3 channels redox sensitive (Bogeski et al., 2010). Post-translational modifications of the protein Glycosylation: |
![]() | |
ORAI3 protein sequence of amino acids. ORAI3 protein (1 .. 295) has four helical transmembrane domains: T1 (63 .. 82) (20 amino acids), T2 (95 .. 115) (21 amino acids), T3 (157 .. 177) (21 amino acids), T4 (244 .. 264) (21 amino acids). | |
Expression | ORAI3 is only expressed in mammals (Cai, 2007). ORAI3 seems to be ubiquitously expressed in human (http://www.proteinatlas.org/ENSG00000175938/tissue), and mouse, showing a minor presence in skeletal muscle, spleen and colon (Cordeiro and Strauss, 2011; Gao et al., 2010; Gross et al., 2007). More specifically, ORAI3 expression has been reported in brain, heart, kidney, testis, intestine, placenta, lung (Gwack et al., 2007; Motiani et al., 2013a), vascular smooth muscle cells (Trebak, 2012), airway smooth muscle in human (Peel et al., 2008) and macrophages. ORAI3 mRNA is usually much less expressed compared to ORAI1 in cells of lymphoid origin. ORAI1, ORAI2, and ORAI3 are expressed at similar levels in rat microglia (Hoth and Niemeyer, 2013). |
Localisation | ORAI3 localizes to the plasma membrane and functions as a Ca2+-selective ion channel (Feske et al., 2006; Vig et al., 2006; Zhang et al., 2006; Prakriya et al., 2006). This has been confirmed by immunocytochemistry of tagged proteins expressed in Jurkat T cells and in HEK293 cells. All three ORAI isoforms are expressed and localized at or near the plasma membrane, with little or no overlap with the ER marker ERP72. This localization was not grossly altered after store depletion with thapsigargin (Gwack et al., 2007). During meiosis, ORAI proteins get internalized into intracellular vesicles and store-operated currents are suppressed (Yu et al., 2009). |
Function | In SOC channels: ORAI3 presents a single putative channel pore and has a role as a store-operated Ca2+ (SOC) channel. SOC channels are the major route for Ca2+ entry in non-excitable cells, and they include ORAI channels characterized by high selectivity for Ca2+ over monovalent cations, low single-channel conductance (<1 pS), and an inwardly rectifying current-voltage (I-V) relationship. Functional CRAC/SOC channels are formed by a tetrameric assembly of ORAI1/2/3 subunits (Ji et al., 2008; Mignen et al., 2008a; Penna et al., 2008; Maruyama et al., 2009). ORAI3 is different from its family members, notably because of its exclusive presence in mammals (Cai, 2007) and its receptivity to pharmacological modulation (Schindl et al., 2008). All three isoforms are selective to Ca2+, ORAI3 being more permeant to monovalent cations such as Na+ (DeHaven et al., 2007). Indeed, the ORAI3 currents display a significantly increased permeability to Na+ when measured in the absence of external divalent cations (Lis et al., 2007). ORAI3 expression is capable of inducing a store-induced conductance, but its magnitude is considerably smaller than that seen with ORAI1. In HEK293 cells, human SCID T cells and fibroblasts, in which store depletion has been induced with thapsigargin, ORAI1 was shown to be the major regulator of store-operated Ca2+ influx, whereas ORAI3 can complement partially (partly compensate in the absence of functional ORAI1) and ORAI2 has a lesser role (Gwack et al., 2007). Combined overexpression of ORAI3 and STIM1 results in substantial reconstitution of Ca2+ entry in SCID fibroblasts (Gwack et al., 2007). ORAI3 expression also rescues normal store-operated Ca2+ entry in cells in which such entry was reduced by knockdown of ORAI1 (Mercer et al., 2006; DeHaven et al., 2007). ORAI1, ORAI2, and ORAI3 channels are all similarly inhibited by extracellular Ca2+, indicating similar affinities for Ca2+ within the selectivity filter. ORAI3 channels seem to differ from ORAI1 and ORAI2 in being somewhat resistant to the process of Ca2+ depotentiation (DeHaven et al., 2007). Moreover, like ORAI1, ORAI3 can potentiate store-operated Ca2+ entry in HEK293 cells expressing TRPC6 or TRPC3 (Liao et al., 2007). ORAI3 and ORAI1 channels participate in store-operated Ca2+ influx in human airway smooth muscle cells (Peel et al., 2008). Cells transfected with siRNA against ORAI3 display abnormal (cyclopiazonic acid) CPA-mediated Ca2+ signals. Both Ca2+ release from the stores and Ca2+ influx are reduced in the ORAI3 knockdown cells, suggesting that cells with reduced ORAI3 expression have a lower Ca2+ store content and that ORAI3 plays a role in regulating basal Ca2+ levels or in Ca2+ release from the stores (Peel et al., 2008). In addition, ORAI genes expression and CRAC activation has also reported in the human retinal pigment epithelium (Potier et al., 2009; Darbellay et al., 2009; Bisaillon et al., 2010). ORAI3 upregulation contributes to vascular smooth muscle remodeling and neointimal hyperplasia caused by vascular injury. ORAI3 has been shown to be an important component of store-independent arachidonate-regulated Ca2+ (ARC) entry in HEK293 cells (Mignen and Shuttleworth, 2000), and more recently of a store-independent leukotriene C4-regulated Ca2+ (LRC) entry pathway in vascular smooth muscle cells (Zhang et al., 2013). In ARC channels: ORAI3 has been identified as an essential component of the store-independent, arachidonic acid activated, Ca2+-selective ARC channels (Mignen and Shuttleworth, 2000; Mignen et al., 2008b). These channels are found in a variety of different cell types, frequently co-existing with store-operated CRAC channels (Mignen et al., 2003; Mignen et al., 2005; Li et al., 2008; Yeung-Yam-Wah et al., 2010), and sharing similar basic biophysical properties. They are pentameric aggregates consisting of three ORAI1 and two ORAI3 subunits that form a functional ARC channel pore (Mignen et al., 2008b; Mignen et al., 2007; Thompson et al., 2010). Two ORAI3 subunits are required within the pentamer to make the ARC channel sensitive to activation by low concentrations of arachidonic acid. ARC channels are characterized by being activated by low concentrations (2-8 μM) of arachidonic acid, insensitive to 2-APB, and with an absolutely dependence on the pool of STIM1 residing in the plasma membrane for their activation (Mignen et al., 2009). The acquisition of selective activation by arachidonic acid depends on the cytosolic N-terminal domain of ORAI3 (Thompson et al., 2010). The ARC currents are distinguished from the co-existing CRAC channel currents by their store-independent activation, and the absence of any detectible fast inactivation. Expression of a dominant-negative mutant of ORAI3 (E81Q) had no effect on store-operated CRAC channel currents, but reduced currents through the store-independent ARC channels to negligible levels (Mignen et al., 2008b). A recent study indicates a role of ARC channels in insulin secretion by pancreatic β cells (Yeung-Yam-Wah et al., 2010). It has been shown that the known ability of glucose and various insulin stimulants including acetylcholine and cholecystokinin to induce increases in cellular arachidonic acid results in activation of ARC channels in the β cells, increasing cytosolic Ca2+ levels and enhancing the subsequent insulin secretion (Yeung-Yam-Wah et al., 2010). In LRC channels: ORAI3 channels are also implicated in store-independent, leukotriene C4 (LTC4)-regulated Ca2+ (LRC) channels. Comparison of AA (arachidonic acid)- and LTC4-activated currents in vascular smooth muscle cells and in HEK293 cells using whole-cell and perforated patch-clamp recording shows indistinguishable non-additive LTC4- and AA-activated currents that both require ORAI1 and ORAI3. This suggests that ARC and LRC conductances are mediated by the same channel. Experiments using a non-metabolizable form of AA or an inhibitor of 5-lipooxygenase suggest that ARC and LRC currents in both cell types can be activated by either LTC4 or AA, with LTC4 being more potent. Although the plasma membrane (PM)-STIM1 was required for current activation by LTC4 and AA under whole-cell patch-clamp recordings in both cell types, ER-STIM1 was sufficient with perforated patch recordings. These results demonstrate that ARC and LRC currents are mediated by the same cellular populations of STIM1, ORAI1, and ORAI3 (Zhang et al., 2013). In summary, ORAI3 proteins contribute to Ca2+ entry into cells through both store-dependent, Ca2+ release-activated Ca2+ (CRAC) channels and store-independent, arachidonic acid (AA)-regulated Ca2+ (ARC) and leukotriene C4 (LTC4)-regulated Ca2+ (LRC) channels (ORAI1/3 heteromultimers). ORAI3 activation and interaction with STIM proteins Interaction between ORAI family members Protein Interactions other than STIM ORAI3 inactivation Pharmacology |
Homology | ORAI3 (encoding gene: MGC13024 located on chromosome 16) has two human homologs: ORAI1 (FLJ14466, chromosome 12) and ORAI2 (C7orf19, chromosome 7) (Feske et al., 2006). ORAI3 made an evolutionary appearance in mammals, evolving from ORAI1 rather than ORAI2 (Cai, 2007) and manifesting conductances that display unique features in their gating, selectivity, regulation and mode of activation (Shuttleworth, 2012). ORAI3 is the 'newest' ORAI family member in the evolutionary tree (Shuttleworth, 2012). Orthologous ORAI3 genes are found in the following species: chimpanzee (98.98% homology), dog (92.20% homology), cow (90.51% homology), rat (89.83% homology), mice (88.48% homology). |
Mutations |
Note | Understanding of the role of ORAI1, and indeed its initial identification, came from the study of patients carrying functionally critical mutations in this gene. To date, no equivalent identification of patients bearing similar mutations in ORAI3 have been identified. (Diseases associated to absence of ORAI2, ORAI3 or STIM2 function have not been identified in human yet). |
Implicated in |
Note | |
Note | ORAI3 overexpression is associated with breast, lung, leukemia and prostate cancers. |
Entity | Breast cancer |
Note | ORAI3 channels are reported to be highly expressed in breast cancer (BC) tissues and breast cancer cell lines MCF-7 and T47D compared to adjacent non cancerous tissues and non cancerous cell lines, respectively (Faouzi et al., 2011). They are also shown to be involved in proliferation, cell cycle progression and survival of BC cells by regulating the G1 phase and G1/S transition regulatory proteins. Thus, ORAI3 knockdown by specific siRNA inhibits cell proliferation, arrests cell cycle progression in G1 phase, and increases apoptosis in these cells (Faouzi et al., 2011). This phenotype is associated with a reduction in CDK4 and CDK2 (cyclin-dependent kinases) and cyclin E and cyclin D1 expression, an accumulation of p21Waf1/Cip1 (a cyclin-dependent kinase inhibitor) and p53 (a tumor-suppressor protein) together with an increase of Bax/Bcl-2 ratio. Interestingly, these effects seem to be specific to cancer cells, since down-regulation of ORAI3 channels does not affect either cell proliferation or cell survival of normal breast cells. Annexin V and 7-AAD double staining and analysis of the anti-apoptotic protein Bcl-2 to the pro-apoptotic protein Bax ratio revealed that the induced cell mortality by ORAI3 knockdown was mainly apoptotic as demonstrated by the increased percentage of Annexin V-positive cells and the increased Bax/Bcl-2. The same study showed that ORAI3 contributes to Ca2+ influx in BC cells where both Store Operated Calcium Entry (SOCE) amplitude and resting [Ca2+]i decreased significantly with ORAI3 knockdown. The authors concluded that the ORAI3 involvement in cell proliferation/survival and cell cycle progression may be at least partially linked to the calcium influx through the channels since the reduction of external calcium concentration [Ca2+]o to 0.2 mM decreases significantly BC cell proliferation (Faouzi et al., 2011). A subsequent study highlighted a correlation between ORAI3 and the oncogene c-myc expression in tumor tissues and in BC cell lines: ORAI3 and c-myc were over-expressed in 70% and 80% cases respectively. Expression of c-myc, as assessed by RT-qPCR, is higher in the MCF-7 cancer cell line than in the non-cancerous MCF-10A cell line. A similar over-expression pattern was shown for ORAI3 in these cell lines (Faouzi et al., 2013). ORAI3 down-regulation reduces both c-myc expression and activity levels exclusively in BC cells, whereas ORAI1 (one of the two mammalian homologs to ORAI3) induced an upregulation of c-myc mRNA. The involvement of c-myc in the ORAI3 signaling was demonstrated when silencing c-myc resulted in closely-similar and non-additive effects to the ones induced by ORAI3 downregulation: decreased cell proliferation, cell cycle arrest with a significant accumulation of the cells in the G0/G1 phase, increased cell mortality (Faouzi et al., 2013). Authors showed that ORAI3 channels affect c-myc, most likely via the MAP Kinase pathway, as demonstrated by decreased phosphorylation levels of extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) after ORAI3 downregulation (Faouzi et al., 2013). Parallel studies also reported that ORAI3 mediates SOCE in estrogen-receptor-positive (ER+) BC cell lines (Motiani et al., 2010), whereas in estrogen-receptor-negative (ER-) BC cell lines, SOCE is mediated by ORAI1. This study was the first to describe SOCE and endogenous calcium release-activated currents (CRAC) that are mediated by native ORAI3 channels and highlights a potential connection between estrogen receptor alpha (ERα) and ORAI3 (Motiani et al., 2010). Authors then reported that knockdown of ERα decreases ORAI3 expression level leading to a decrease in ORAI3-mediated SOCE and CRAC current, while activation of ERα increased ORAI3 expression and SOCE in MCF7 cells (Motiani et al., 2013b). Consistently with the above cited studies, ORAI3 knockdown inhibits SOCE-dependent phosphorylation of both ERK1/2 and focal adhesion kinase (FAK). It also decreases the transcriptional activity of nuclear factor of activated T-cells (NFAT), which was associated with decreased cell growth and Matrigel invasion of ER+ MCF7 cells in contrast to ER- MDA-MB231 cells where no effects were observed (Motiani et al., 2013b). |
Entity | Lung cancer |
Note | An overexpression of ORAI3 was observed in 66.7% of human tumor samples as compared to the human non-tumoral samples (40/60) as revealed by immunohistochemistry. The 60 lung adenocarcinomas were classified according to grading system proposed by Yoshizawa et al. 2011 (low, intermediate and high grades). The ORAI3 staining score is reported to be highly expressed in higher tumor grade (high grade; n= 16) as compared to low tumor grades (Ay et al., 2013). ORAI3 is also expressed in non small cell lung carcinoma cells (NSCLCC) such as NCI-H23, NCI-H460, A549 and Calu-1. In NCI-H23 and NCI-H460 cells, ORAI3 is a major actor of Store Operated Calcium Entry (Ay et al., 2013). Ay et al. (2013) demonstrated that ORAI3 is involved in NSCLCC proliferation. Indeed, ORAI3 inhibition induces a strong decrease in NSCLCC proliferation, accumulating cells in G0/G1 phase of the cell cycle. This accumulation in G0/G1 phase is associated with a decrease in Cyclin D1/cdk4 and Cyclin E/cdk2 proteins level. No effect is observed on apoptosis. The same study demonstrated that SOCE induces Akt phosphorylation in NSCLCC and ORAI3 inhibition decreases this activation demonstrating ORAI3 can promote proliferation through SOCE by activating Akt pathway. They also showed that neither ORAI1 nor ORAI2 are involved in SOCE in NSCLC cell lines, suggesting that ORAI3 is the main component of SOCE in those cells (Ay et al., 2013). The same type of mechanism is observed with TRPC1 in NSCLCC. Indeed Tajeddine and Gailly (2012) have demonstrated that TRPC1 is involved in G1/S transition in A549 NSCLC cell line through SOCE. They showed that cell cycle arrest after TRPC1 inhibition induces a decrease in EGFR activation and subsequent signaling (PI3K/Akt, MAPK). Those two studies suggest that SOCE is an important mechanism in proliferation of NSCLCC. Indeed, EGFR signaling is overactivated in NSCLCC either by constitutive activation of EGFR or K-Ras mutation. ORAI3, able to activate this pathway, hence can be a potential target for anti-cancer drug. |
Entity | Myeloid leukemia |
Note | The mRNA levels of ORAI3 in both human leukemia and human myeloma tipifarnib-sensitive cell lines were significantly higher than in the tipifarnib-insensitive human myeloma cells. Tipifarnib is a new apoptotic agent that inhibits farnesyltransferase responsible for the transfer of a farnesyl group to Ras protein. Tipifarnib activates ORAI3-mediated SOC leading to [Ca2+]i increase. Moreover, ORAI3 functional expression was higher in 2-APB-sensitive leukemia and myeloid cells as compared to 2-APB-insensitive myeloid cells (Yanamadra et al., 2011). These results suggest that Tipifarnib-resistant cells express less ORAI3 ORAI3 conferring protection against apoptotic effect of Tipifarnib (Yanamadra et al., 2011). |
Entity | Prostate cancer |
Note | ORAI3 mRNA expression levels are significantly reduced in tumours when compared to non-tumour tissues from 13 prostate cancer patients. mRNA expression levels of ORAI3 are decreased in both androgen-sensitive human prostate adenocarcinoma cell line (LNCaP) and androgen-insensitive prostate cancer cell line (DU145), when compared to human prostate epithelial cells from healthy tissue. The pharmacological effects of 2-APB on CRAC channels in prostate cancer cells differ from those in human prostate epithelial cells, and siRNA based knock-down experiments indicate changed ORAI3 channel levels are underlying the altered pharmacological profile (Holzmann et al., 2013). |
Bibliography |
State-dependent block of Orai3 TM1 and TM3 cysteine mutants: insights into 2-APB activation. |
Amcheslavsky A, Safrina O, Cahalan MD. |
J Gen Physiol. 2014 May;143(5):621-31. doi: 10.1085/jgp.201411171. Epub 2014 Apr 14. |
PMID 24733836 |
Orai3 constitutes a native store-operated calcium entry that regulates non small cell lung adenocarcinoma cell proliferation. |
Ay AS, Benzerdjerb N, Sevestre H, Ahidouch A, Ouadid-Ahidouch H. |
PLoS One. 2013 Sep 13;8(9):e72889. doi: 10.1371/journal.pone.0072889. eCollection 2013. |
PMID 24058448 |
Coupling of STIM1 to store-operated Ca2+ entry through its constitutive and inducible movement in the endoplasmic reticulum. |
Baba Y, Hayashi K, Fujii Y, Mizushima A, Watarai H, Wakamori M, Numaga T, Mori Y, Iino M, Hikida M, Kurosaki T. |
Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16704-9. Epub 2006 Oct 30. |
PMID 17075073 |
Molecular determinants within N terminus of Orai3 protein that control channel activation and gating. |
Bergsmann J, Derler I, Muik M, Frischauf I, Fahrner M, Pollheimer P, Schwarzinger C, Gruber HJ, Groschner K, Romanin C. |
J Biol Chem. 2011 Sep 9;286(36):31565-75. doi: 10.1074/jbc.M111.227546. Epub 2011 Jul 1. |
PMID 21724845 |
Inhibition of the type 1 inositol 1,4,5-trisphosphate receptor by 2-aminoethoxydiphenylborate. |
Bilmen JG, Michelangeli F. |
Cell Signal. 2002 Nov;14(11):955-60. |
PMID 12220621 |
Essential role for STIM1/Orai1-mediated calcium influx in PDGF-induced smooth muscle migration. |
Bisaillon JM, Motiani RK, Gonzalez-Cobos JC, Potier M, Halligan KE, Alzawahra WF, Barroso M, Singer HA, Jourd'heuil D, Trebak M. |
Am J Physiol Cell Physiol. 2010 May;298(5):C993-1005. doi: 10.1152/ajpcell.00325.2009. Epub 2010 Jan 27. |
PMID 20107038 |
Differential redox regulation of ORAI ion channels: a mechanism to tune cellular calcium signaling. |
Bogeski I, Kummerow C, Al-Ansary D, Schwarz EC, Koehler R, Kozai D, Takahashi N, Peinelt C, Griesemer D, Bozem M, Mori Y, Hoth M, Niemeyer BA. |
Sci Signal. 2010 Mar 30;3(115):ra24. doi: 10.1126/scisignal.2000672. |
PMID 20354224 |
Molecular evolution and structural analysis of the Ca(2+) release-activated Ca(2+) channel subunit, Orai. |
Cai X. |
J Mol Biol. 2007 May 18;368(5):1284-91. Epub 2007 Mar 15. |
PMID 17400243 |
2-aminoethoxydiphenyl borate activates and sensitizes the heat-gated ion channel TRPV3. |
Chung MK, Lee H, Mizuno A, Suzuki M, Caterina MJ. |
J Neurosci. 2004 Jun 2;24(22):5177-82. |
PMID 15175387 |
Expression of Orai genes and I(CRAC) activation in the human retinal pigment epithelium. |
Cordeiro S, Strauss O. |
Graefes Arch Clin Exp Ophthalmol. 2011 Jan;249(1):47-54. doi: 10.1007/s00417-010-1445-3. Epub 2010 Jul 6. |
PMID 20607548 |
STIM1- and Orai1-dependent store-operated calcium entry regulates human myoblast differentiation. |
Darbellay B, Arnaudeau S, Konig S, Jousset H, Bader C, Demaurex N, Bernheim L. |
J Biol Chem. 2009 Feb 20;284(8):5370-80. doi: 10.1074/jbc.M806726200. Epub 2008 Dec 16. |
PMID 19088073 |
Complex actions of 2-aminoethyldiphenyl borate on store-operated calcium entry. |
DeHaven WI, Smyth JT, Boyles RR, Bird GS, Putney JW Jr. |
J Biol Chem. 2008 Jul 11;283(28):19265-73. doi: 10.1074/jbc.M801535200. Epub 2008 May 16. |
PMID 18487204 |
A Ca2(+ )release-activated Ca2(+) (CRAC) modulatory domain (CMD) within STIM1 mediates fast Ca2(+)-dependent inactivation of ORAI1 channels. |
Derler I, Fahrner M, Muik M, Lackner B, Schindl R, Groschner K, Romanin C. |
J Biol Chem. 2009 Sep 11;284(37):24933-8. doi: 10.1074/jbc.C109.024083. Epub 2009 Jul 21. |
PMID 19622747 |
Structure, regulation and biophysics of I(CRAC), STIM/Orai1. |
Derler I, Madl J, Schutz G, Romanin C. |
Adv Exp Med Biol. 2012;740:383-410. doi: 10.1007/978-94-007-2888-2_16. (REVIEW) |
PMID 22453951 |
Mechanistic view on domains mediating STIM1-Orai coupling. |
Fahrner M, Muik M, Derler I, Schindl R, Fritsch R, Frischauf I, Romanin C. |
Immunol Rev. 2009 Sep;231(1):99-112. doi: 10.1111/j.1600-065X.2009.00815.x. (REVIEW) |
PMID 19754892 |
Down-regulation of Orai3 arrests cell-cycle progression and induces apoptosis in breast cancer cells but not in normal breast epithelial cells. |
Faouzi M, Hague F, Potier M, Ahidouch A, Sevestre H, Ouadid-Ahidouch H. |
J Cell Physiol. 2011 Feb;226(2):542-51. doi: 10.1002/jcp.22363. |
PMID 20683915 |
ORAI3 silencing alters cell proliferation and cell cycle progression via c-myc pathway in breast cancer cells. |
Faouzi M, Kischel P, Hague F, Ahidouch A, Benzerdjeb N, Sevestre H, Penner R, Ouadid-Ahidouch H. |
Biochim Biophys Acta. 2013 Mar;1833(3):752-60. doi: 10.1016/j.bbamcr.2012.12.009. Epub 2012 Dec 22. |
PMID 23266555 |
Store-independent activation of Orai1 by SPCA2 in mammary tumors. |
Feng M, Grice DM, Faddy HM, Nguyen N, Leitch S, Wang Y, Muend S, Kenny PA, Sukumar S, Roberts-Thomson SJ, Monteith GR, Rao R. |
Cell. 2010 Oct 1;143(1):84-98. doi: 10.1016/j.cell.2010.08.040. |
PMID 20887894 |
A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. |
Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa B, Hogan PG, Lewis RS, Daly M, Rao A. |
Nature. 2006 May 11;441(7090):179-85. Epub 2006 Apr 2. |
PMID 16582901 |
Cooperativeness of Orai cytosolic domains tunes subtype-specific gating. |
Frischauf I, Schindl R, Bergsmann J, Derler I, Fahrner M, Muik M, Fritsch R, Lackner B, Groschner K, Romanin C. |
J Biol Chem. 2011 Mar 11;286(10):8577-84. doi: 10.1074/jbc.M110.187179. Epub 2011 Jan 10. |
PMID 21220423 |
Calcium-activated K(+) channel (K(Ca)3.1) activity during Ca(2+) store depletion and store-operated Ca(2+) entry in human macrophages. |
Gao YD, Hanley PJ, Rinne S, Zuzarte M, Daut J. |
Cell Calcium. 2010 Jul;48(1):19-27. doi: 10.1016/j.ceca.2010.06.002. Epub 2010 Jul 14. |
PMID 20630587 |
Evidence that 2-aminoethyl diphenylborate is a novel inhibitor of store-operated Ca2+ channels in liver cells, and acts through a mechanism which does not involve inositol trisphosphate receptors. |
Gregory RB, Rychkov G, Barritt GJ. |
Biochem J. 2001 Mar 1;354(Pt 2):285-90. |
PMID 11171105 |
Murine ORAI2 splice variants form functional Ca2+ release-activated Ca2+ (CRAC) channels. |
Gross SA, Wissenbach U, Philipp SE, Freichel M, Cavalie A, Flockerzi V. |
J Biol Chem. 2007 Jul 6;282(27):19375-84. Epub 2007 Apr 26. |
PMID 17463004 |
Biochemical and functional characterization of Orai proteins. |
Gwack Y, Srikanth S, Feske S, Cruz-Guilloty F, Oh-hora M, Neems DS, Hogan PG, Rao A. |
J Biol Chem. 2007 Jun 1;282(22):16232-43. Epub 2007 Feb 9. |
PMID 17293345 |
Role of STIM and Orai proteins in the store-operated calcium signaling pathway. |
Hewavitharana T, Deng X, Soboloff J, Gill DL. |
Cell Calcium. 2007 Aug;42(2):173-82. Epub 2007 Jun 28. (REVIEW) |
PMID 17602740 |
ICRAC controls the rapid androgen response in human primary prostate epithelial cells and is altered in prostate cancer. |
Holzmann C, Kilch T, Kappel S, Armbruster A, Jung V, Stockle M, Bogeski I, Schwarz EC, Peinelt C. |
Oncotarget. 2013 Nov;4(11):2096-107. |
PMID 24240085 |
The neglected CRAC proteins: Orai2, Orai3, and STIM2. |
Hoth M, Niemeyer BA. |
Curr Top Membr. 2013;71:237-71. doi: 10.1016/B978-0-12-407870-3.00010-X. (REVIEW) |
PMID 23890118 |
MS4A4B is a GITR-associated membrane adapter, expressed by regulatory T cells, which modulates T cell activation. |
Howie D, Nolan KF, Daley S, Butterfield E, Adams E, Garcia-Rueda H, Thompson C, Saunders NJ, Cobbold SP, Tone Y, Tone M, Waldmann H. |
J Immunol. 2009 Oct 1;183(7):4197-204. doi: 10.4049/jimmunol.0901070. Epub 2009 Sep 14. |
PMID 19752228 |
2-aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2, and TRPV3. |
Hu HZ, Gu Q, Wang C, Colton CK, Tang J, Kinoshita-Kawada M, Lee LY, Wood JD, Zhu MX. |
J Biol Chem. 2004 Aug 20;279(34):35741-8. Epub 2004 Jun 11. |
PMID 15194687 |
2-Aminoethoxydiphenyl borate (2-APB) inhibits capacitative calcium entry independently of the function of inositol 1,4,5-trisphosphate receptors. |
Iwasaki H, Mori Y, Hara Y, Uchida K, Zhou H, Mikoshiba K. |
Receptors Channels. 2001;7(6):429-39. |
PMID 11918346 |
Functional stoichiometry of the unitary calcium-release-activated calcium channel. |
Ji W, Xu P, Li Z, Lu J, Liu L, Zhan Y, Chen Y, Hille B, Xu T, Chen L. |
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13668-73. doi: 10.1073/pnas.0806499105. Epub 2008 Aug 29. |
PMID 18757751 |
Pharmacological characterization and molecular determinants of the activation of transient receptor potential V2 channel orthologs by 2-aminoethoxydiphenyl borate. |
Juvin V, Penna A, Chemin J, Lin YL, Rassendren FA. |
Mol Pharmacol. 2007 Nov;72(5):1258-68. Epub 2007 Aug 2. |
PMID 17673572 |
Protein kinase C-induced phosphorylation of Orai1 regulates the intracellular Ca2+ level via the store-operated Ca2+ channel. |
Kawasaki T, Ueyama T, Lange I, Feske S, Saito N. |
J Biol Chem. 2010 Aug 13;285(33):25720-30. doi: 10.1074/jbc.M109.022996. Epub 2010 Jun 9. |
PMID 20534587 |
Dependence of STIM1/Orai1-mediated calcium entry on plasma membrane phosphoinositides. |
Korzeniowski MK, Popovic MA, Szentpetery Z, Varnai P, Stojilkovic SS, Balla T. |
J Biol Chem. 2009 Jul 31;284(31):21027-35. doi: 10.1074/jbc.M109.012252. Epub 2009 May 29. |
PMID 19483082 |
Molecular determinants of fast Ca2+-dependent inactivation and gating of the Orai channels. |
Lee KP, Yuan JP, Zeng W, So I, Worley PF, Muallem S. |
Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14687-92. doi: 10.1073/pnas.0904664106. Epub 2009 Aug 12. |
PMID 19706554 |
Alterations of concentrations of calcium and arachidonic acid and agglutinations of microfilaments in host cells during Toxoplasma gondii invasion. |
Li L, Li X, Yan J. |
Vet Parasitol. 2008 Oct 20;157(1-2):21-33. doi: 10.1016/j.vetpar.2008.07.007. Epub 2008 Jul 23. |
PMID 18706765 |
Functional characterization of homo- and heteromeric channel kinases TRPM6 and TRPM7. |
Li M, Jiang J, Yue L. |
J Gen Physiol. 2006 May;127(5):525-37. |
PMID 16636202 |
Mapping the interacting domains of STIM1 and Orai1 in Ca2+ release-activated Ca2+ channel activation. |
Li Z, Lu J, Xu P, Xie X, Chen L, Xu T. |
J Biol Chem. 2007 Oct 5;282(40):29448-56. Epub 2007 Aug 16. |
PMID 17702753 |
Orai proteins interact with TRPC channels and confer responsiveness to store depletion. |
Liao Y, Erxleben C, Yildirim E, Abramowitz J, Armstrong DL, Birnbaumer L. |
Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4682-7. Epub 2007 Mar 7. |
PMID 17360584 |
STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. |
Liou J, Kim ML, Heo WD, Jones JT, Myers JW, Ferrell JE Jr, Meyer T. |
Curr Biol. 2005 Jul 12;15(13):1235-41. |
PMID 16005298 |
CRACM1, CRACM2, and CRACM3 are store-operated Ca2+ channels with distinct functional properties. |
Lis A, Peinelt C, Beck A, Parvez S, Monteilh-Zoller M, Fleig A, Penner R. |
Curr Biol. 2007 May 1;17(9):794-800. Epub 2007 Apr 19. |
PMID 17442569 |
A single lysine in the N-terminal region of store-operated channels is critical for STIM1-mediated gating. |
Lis A, Zierler S, Peinelt C, Fleig A, Penner R. |
J Gen Physiol. 2010 Dec;136(6):673-86. doi: 10.1085/jgp.201010484. |
PMID 21115697 |
Fast Ca(2+)-dependent inactivation of the store-operated Ca2+ current (ISOC) in liver cells: a role for calmodulin. |
Litjens T, Harland ML, Roberts ML, Barritt GJ, Rychkov GY. |
J Physiol. 2004 Jul 1;558(Pt 1):85-97. Epub 2004 Apr 30. |
PMID 15226409 |
Oligomerization of STIM1 couples ER calcium depletion to CRAC channel activation. |
Luik RM, Wang B, Prakriya M, Wu MM, Lewis RS. |
Nature. 2008 Jul 24;454(7203):538-42. doi: 10.1038/nature07065. Epub 2008 Jul 2. |
PMID 18596693 |
The elementary unit of store-operated Ca2+ entry: local activation of CRAC channels by STIM1 at ER-plasma membrane junctions. |
Luik RM, Wu MM, Buchanan J, Lewis RS. |
J Cell Biol. 2006 Sep 11;174(6):815-25. |
PMID 16966423 |
Capacitative Ca2+ entry via Orai1 and stromal interacting molecule 1 (STIM1) regulates adenylyl cyclase type 8. |
Martin AC, Willoughby D, Ciruela A, Ayling LJ, Pagano M, Wachten S, Tengholm A, Cooper DM. |
Mol Pharmacol. 2009 Apr;75(4):830-42. doi: 10.1124/mol.108.051748. Epub 2009 Jan 26. |
PMID 19171672 |
2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of Ins(1,4,5)P3-induced Ca2+ release. |
Maruyama T, Kanaji T, Nakade S, Kanno T, Mikoshiba K. |
J Biochem. 1997 Sep;122(3):498-505. |
PMID 9348075 |
Tetrameric Orai1 is a teardrop-shaped molecule with a long, tapered cytoplasmic domain. |
Maruyama Y, Ogura T, Mio K, Kato K, Kaneko T, Kiyonaka S, Mori Y, Sato C. |
J Biol Chem. 2009 May 15;284(20):13676-85. doi: 10.1074/jbc.M900812200. Epub 2009 Mar 16. |
PMID 19289460 |
Structural determinants of ion permeation in CRAC channels. |
McNally BA, Yamashita M, Engh A, Prakriya M. |
Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22516-21. doi: 10.1073/pnas.0909574106. Epub 2009 Dec 11. |
PMID 20018736 |
Large store-operated calcium selective currents due to co-expression of Orai1 or Orai2 with the intracellular calcium sensor, Stim1. |
Mercer JC, Dehaven WI, Smyth JT, Wedel B, Boyles RR, Bird GS, Putney JW Jr. |
J Biol Chem. 2006 Aug 25;281(34):24979-90. Epub 2006 Jun 28. |
PMID 16807233 |
I(ARC), a novel arachidonate-regulated, noncapacitative Ca(2+) entry channel. |
Mignen O, Shuttleworth TJ. |
J Biol Chem. 2000 Mar 31;275(13):9114-9. |
PMID 10734044 |
The molecular architecture of the arachidonate-regulated Ca2+-selective ARC channel is a pentameric assembly of Orai1 and Orai3 subunits. |
Mignen O, Thompson JL, Shuttleworth TJ. |
J Physiol. 2009 Sep 1;587(Pt 17):4181-97. doi: 10.1113/jphysiol.2009.174193. Epub 2009 Jul 21. |
PMID 19622606 |
2-Aminoethoxydiphenyl borate affects the inositol 1,4,5-trisphosphate receptor, the intracellular Ca2+ pump and the non-specific Ca2+ leak from the non-mitochondrial Ca2+ stores in permeabilized A7r5 cells. |
Missiaen L, Callewaert G, De Smedt H, Parys JB. |
Cell Calcium. 2001 Feb;29(2):111-6. |
PMID 11162848 |
Orai3 is an estrogen receptor alpha-regulated Ca2(+) channel that promotes tumorigenesis. |
Motiani RK, Zhang X, Harmon KE, Keller RS, Matrougui K, Bennett JA, Trebak M. |
FASEB J. 2013b Jan;27(1):63-75. doi: 10.1096/fj.12-213801. Epub 2012 Sep 19. |
PMID 22993197 |
A Cytosolic Homomerization and a Modulatory Domain within STIM1 C Terminus Determine Coupling to ORAI1 Channels. |
Muik M, Fahrner M, Derler I, Schindl R, Bergsmann J, Frischauf I, Groschner K, Romanin C. |
J Biol Chem. 2009 Mar 27;284(13):8421-6. doi: 10.1074/jbc.C800229200. Epub 2009 Feb 3. |
PMID 19189966 |
Dynamic coupling of the putative coiled-coil domain of ORAI1 with STIM1 mediates ORAI1 channel activation. |
Muik M, Frischauf I, Derler I, Fahrner M, Bergsmann J, Eder P, Schindl R, Hesch C, Polzinger B, Fritsch R, Kahr H, Madl J, Gruber H, Groschner K, Romanin C. |
J Biol Chem. 2008 Mar 21;283(12):8014-22. doi: 10.1074/jbc.M708898200. Epub 2008 Jan 10. |
PMID 18187424 |
STIM1 and calmodulin interact with Orai1 to induce Ca2+-dependent inactivation of CRAC channels. |
Mullins FM, Park CY, Dolmetsch RE, Lewis RS. |
Proc Natl Acad Sci U S A. 2009 Sep 8;106(36):15495-500. doi: 10.1073/pnas.0906781106. Epub 2009 Aug 21. |
PMID 19706428 |
SARAF inactivates the store operated calcium entry machinery to prevent excess calcium refilling. |
Palty R, Raveh A, Kaminsky I, Meller R, Reuveny E. |
Cell. 2012 Apr 13;149(2):425-38. doi: 10.1016/j.cell.2012.01.055. Epub 2012 Mar 29. |
PMID 22464749 |
Store-operated calcium channels. |
Parekh AB, Putney JW Jr. |
Physiol Rev. 2005 Apr;85(2):757-810. (REVIEW) |
PMID 15788710 |
STIM1 clusters and activates CRAC channels via direct binding of a cytosolic domain to Orai1. |
Park CY, Hoover PJ, Mullins FM, Bachhawat P, Covington ED, Raunser S, Walz T, Garcia KC, Dolmetsch RE, Lewis RS. |
Cell. 2009 Mar 6;136(5):876-90. doi: 10.1016/j.cell.2009.02.014. Epub 2009 Feb 26. |
PMID 19249086 |
STIM2 protein mediates distinct store-dependent and store-independent modes of CRAC channel activation. |
Parvez S, Beck A, Peinelt C, Soboloff J, Lis A, Monteilh-Zoller M, Gill DL, Fleig A, Penner R. |
FASEB J. 2008 Mar;22(3):752-61. Epub 2007 Sep 28. |
PMID 17905723 |
ORAI and store-operated calcium influx in human airway smooth muscle cells. |
Peel SE, Liu B, Hall IP. |
Am J Respir Cell Mol Biol. 2008 Jun;38(6):744-9. doi: 10.1165/rcmb.2007-0395OC. Epub 2008 Jan 31. |
PMID 18239188 |
2-Aminoethoxydiphenyl borate directly facilitates and indirectly inhibits STIM1-dependent gating of CRAC channels. |
Peinelt C, Lis A, Beck A, Fleig A, Penner R. |
J Physiol. 2008 Jul 1;586(13):3061-73. doi: 10.1113/jphysiol.2008.151365. Epub 2008 Apr 10. |
PMID 18403424 |
The CRAC channel consists of a tetramer formed by Stim-induced dimerization of Orai dimers. |
Penna A, Demuro A, Yeromin AV, Zhang SL, Safrina O, Parker I, Cahalan MD. |
Nature. 2008 Nov 6;456(7218):116-20. doi: 10.1038/nature07338. Epub 2008 Sep 28. |
PMID 18820677 |
2-Aminoethoxydiphenyl borate (2-APB) antagonises inositol 1,4,5-trisphosphate-induced calcium release, inhibits calcium pumps and has a use-dependent and slowly reversible action on store-operated calcium entry channels. |
Peppiatt CM, Collins TJ, Mackenzie L, Conway SJ, Holmes AB, Bootman MD, Berridge MJ, Seo JT, Roderick HL. |
Cell Calcium. 2003 Jul;34(1):97-108. |
PMID 12767897 |
Evidence for STIM1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: role in proliferation and migration. |
Potier M, Gonzalez JC, Motiani RK, Abdullaev IF, Bisaillon JM, Singer HA, Trebak M. |
FASEB J. 2009 Aug;23(8):2425-37. doi: 10.1096/fj.09-131128. Epub 2009 Apr 13. |
PMID 19364762 |
Orai1 is an essential pore subunit of the CRAC channel. |
Prakriya M, Feske S, Gwack Y, Srikanth S, Rao A, Hogan PG. |
Nature. 2006 Sep 14;443(7108):230-3. Epub 2006 Aug 20. |
PMID 16921383 |
STIM1, an essential and conserved component of store-operated Ca2+ channel function. |
Roos J, DiGregorio PJ, Yeromin AV, Ohlsen K, Lioudyno M, Zhang S, Safrina O, Kozak JA, Wagner SL, Cahalan MD, Velicelebi G, Stauderman KA. |
J Cell Biol. 2005 May 9;169(3):435-45. Epub 2005 May 2. |
PMID 15866891 |
2-aminoethoxydiphenyl borate alters selectivity of Orai3 channels by increasing their pore size. |
Schindl R, Bergsmann J, Frischauf I, Derler I, Fahrner M, Muik M, Fritsch R, Groschner K, Romanin C. |
J Biol Chem. 2008 Jul 18;283(29):20261-7. doi: 10.1074/jbc.M803101200. Epub 2008 May 21. |
PMID 18499656 |
Plasticity in Ca2+ selectivity of Orai1/Orai3 heteromeric channel. |
Schindl R, Frischauf I, Bergsmann J, Muik M, Derler I, Lackner B, Groschner K, Romanin C. |
Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19623-8. doi: 10.1073/pnas.0907714106. Epub 2009 Nov 3. |
PMID 19887627 |
Orai3--the 'exceptional' Orai? |
Shuttleworth TJ. |
J Physiol. 2012 Jan 15;590(Pt 2):241-57. doi: 10.1113/jphysiol.2011.220574. Epub 2011 Oct 31. (REVIEW) |
PMID 22041188 |
Ca2+-store-dependent and -independent reversal of Stim1 localization and function. |
Smyth JT, Dehaven WI, Bird GS, Putney JW Jr. |
J Cell Sci. 2008 Mar 15;121(Pt 6):762-72. doi: 10.1242/jcs.023903. Epub 2008 Feb 19. |
PMID 18285445 |
Calcium signals mediated by STIM and Orai proteins--a new paradigm in inter-organelle communication. |
Soboloff J, Spassova MA, Dziadek MA, Gill DL. |
Biochim Biophys Acta. 2006 Nov;1763(11):1161-8. Epub 2006 Sep 20. (REVIEW) |
PMID 17084918 |
The intracellular loop of Orai1 plays a central role in fast inactivation of Ca2+ release-activated Ca2+ channels. |
Srikanth S, Jung HJ, Ribalet B, Gwack Y. |
J Biol Chem. 2010 Feb 12;285(7):5066-75. doi: 10.1074/jbc.M109.072736. Epub 2009 Dec 10. |
PMID 20007711 |
Stored Ca2+ depletion-induced oligomerization of stromal interaction molecule 1 (STIM1) via the EF-SAM region: An initiation mechanism for capacitive Ca2+ entry. |
Stathopulos PB, Li GY, Plevin MJ, Ames JB, Ikura M. |
J Biol Chem. 2006 Nov 24;281(47):35855-62. Epub 2006 Oct 3. |
PMID 17020874 |
Phosphoproteome analysis of the human Chang liver cells using SCX and a complementary mass spectrometric strategy. |
Sui S, Wang J, Yang B, Song L, Zhang J, Chen M, Liu J, Lu Z, Cai Y, Chen S, Bi W, Zhu Y, He F, Qian X. |
Proteomics. 2008 May;8(10):2024-34. doi: 10.1002/pmic.200700896. |
PMID 18491316 |
TRPC1 protein channel is major regulator of epidermal growth factor receptor signaling. |
Tajeddine N, Gailly P. |
J Biol Chem. 2012 May 11;287(20):16146-57. doi: 10.1074/jbc.M112.340034. Epub 2012 Mar 26. |
PMID 22451676 |
Essential role of the N-terminus of murine Orai1 in store-operated Ca2+ entry. |
Takahashi Y, Murakami M, Watanabe H, Hasegawa H, Ohba T, Munehisa Y, Nobori K, Ono K, Iijima T, Ito H. |
Biochem Biophys Res Commun. 2007 Apr 27;356(1):45-52. Epub 2007 Feb 28. |
PMID 17343823 |
The N-terminal domain of Orai3 determines selectivity for activation of the store-independent ARC channel by arachidonic acid. |
Thompson J, Mignen O, Shuttleworth TJ. |
Channels (Austin). 2010 Sep-Oct;4(5):398-410. doi: 10.4161/chan.4.5.13226. Epub 2010 Sep 1. |
PMID 20818184 |
Comparison of human TRPC3 channels in receptor-activated and store-operated modes. Differential sensitivity to channel blockers suggests fundamental differences in channel composition. |
Trebak M, Bird GS, McKay RR, Putney JW Jr. |
J Biol Chem. 2002 Jun 14;277(24):21617-23. Epub 2002 Apr 9. |
PMID 11943785 |
STIM/Orai signalling complexes in vascular smooth muscle. |
Trebak M. |
J Physiol. 2012 Sep 1;590(Pt 17):4201-8. doi: 10.1113/jphysiol.2012.233353. Epub 2012 May 28. (REVIEW) |
PMID 22641780 |
Visualization and manipulation of plasma membrane-endoplasmic reticulum contact sites indicates the presence of additional molecular components within the STIM1-Orai1 Complex. |
Varnai P, Toth B, Toth DJ, Hunyady L, Balla T. |
J Biol Chem. 2007 Oct 5;282(40):29678-90. Epub 2007 Aug 7. |
PMID 17684017 |
CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry. |
Vig M, Peinelt C, Beck A, Koomoa DL, Rabah D, Koblan-Huberson M, Kraft S, Turner H, Fleig A, Penner R, Kinet JP. |
Science. 2006 May 26;312(5777):1220-3. Epub 2006 Apr 27. |
PMID 16645049 |
CaT1 and the calcium release-activated calcium channel manifest distinct pore properties. |
Voets T, Prenen J, Fleig A, Vennekens R, Watanabe H, Hoenderop JG, Bindels RJ, Droogmans G, Penner R, Nilius B. |
J Biol Chem. 2001 Dec 21;276(51):47767-70. Epub 2001 Oct 30. |
PMID 11687570 |
Role of phosphoinositides in STIM1 dynamics and store-operated calcium entry. |
Walsh CM, Chvanov M, Haynes LP, Petersen OH, Tepikin AV, Burgoyne RD. |
Biochem J. 2009 Dec 14;425(1):159-68. doi: 10.1042/BJ20090884. |
PMID 19843011 |
Evidence for an interaction between Golli and STIM1 in store-operated calcium entry. |
Walsh CM, Doherty MK, Tepikin AV, Burgoyne RD. |
Biochem J. 2010 Sep 15;430(3):453-60. doi: 10.1042/BJ20100650. |
PMID 20629634 |
The calcium store sensor, STIM1, reciprocally controls Orai and CaV1.2 channels. |
Wang Y, Deng X, Mancarella S, Hendron E, Eguchi S, Soboloff J, Tang XD, Gill DL. |
Science. 2010 Oct 1;330(6000):105-9. doi: 10.1126/science.1191086. |
PMID 20929813 |
Identification and characterization of the STIM (stromal interaction molecule) gene family: coding for a novel class of transmembrane proteins. |
Williams RT, Manji SS, Parker NJ, Hancock MS, Van Stekelenburg L, Eid JP, Senior PV, Kazenwadel JS, Shandala T, Saint R, Smith PJ, Dziadek MA. |
Biochem J. 2001 Aug 1;357(Pt 3):673-85. |
PMID 11463338 |
Identification of a polycystin-1 cleavage product, P100, that regulates store operated Ca entry through interactions with STIM1. |
Woodward OM, Li Y, Yu S, Greenwell P, Wodarczyk C, Boletta A, Guggino WB, Qian F. |
PLoS One. 2010 Aug 23;5(8):e12305. doi: 10.1371/journal.pone.0012305. |
PMID 20808796 |
Ca2+ store depletion causes STIM1 to accumulate in ER regions closely associated with the plasma membrane. |
Wu MM, Buchanan J, Luik RM, Lewis RS. |
J Cell Biol. 2006 Sep 11;174(6):803-13. |
PMID 16966422 |
Competitive modulation of Ca2+ release-activated Ca2+ channel gating by STIM1 and 2-aminoethyldiphenyl borate. |
Yamashita M, Somasundaram A, Prakriya M. |
J Biol Chem. 2011 Mar 18;286(11):9429-42. doi: 10.1074/jbc.M110.189035. Epub 2010 Dec 30. |
PMID 21193399 |
Tipifarnib-induced apoptosis in acute myeloid leukemia and multiple myeloma cells depends on Ca2+ influx through plasma membrane Ca2+ channels. |
Yanamandra N, Buzzeo RW, Gabriel M, Hazlehurst LA, Mari Y, Beaupre DM, Cuevas J. |
J Pharmacol Exp Ther. 2011 Jun;337(3):636-43. doi: 10.1124/jpet.110.172809. Epub 2011 Mar 4. |
PMID 21378206 |
Arachidonic acid stimulates extracellular Ca(2+) entry in rat pancreatic beta cells via activation of the noncapacitative arachidonate-regulated Ca(2+) (ARC) channels. |
Yeung-Yam-Wah V, Lee AK, Tse FW, Tse A. |
Cell Calcium. 2010 Jan;47(1):77-83. doi: 10.1016/j.ceca.2009.11.007. Epub 2009 Dec 16. |
PMID 20018371 |
Constitutive recycling of the store-operated Ca2+ channel Orai1 and its internalization during meiosis. |
Yu F, Sun L, Machaca K. |
J Cell Biol. 2010 Nov 1;191(3):523-35. doi: 10.1083/jcb.201006022. |
PMID 21041445 |
SOAR and the polybasic STIM1 domains gate and regulate Orai channels. |
Yuan JP, Zeng W, Dorwart MR, Choi YJ, Worley PF, Muallem S. |
Nat Cell Biol. 2009 Mar;11(3):337-43. doi: 10.1038/ncb1842. Epub 2009 Feb 1. |
PMID 19182790 |
The ryanodine receptor agonist 4-chloro-3-ethylphenol blocks ORAI store-operated channels. |
Zeng B, Chen GL, Daskoulidou N, Xu SZ. |
Br J Pharmacol. 2014 Mar;171(5):1250-9. doi: 10.1111/bph.12528. |
PMID 24670147 |
Store-dependent and -independent modes regulating Ca2+ release-activated Ca2+ channel activity of human Orai1 and Orai3. |
Zhang SL, Kozak JA, Jiang W, Yeromin AV, Chen J, Yu Y, Penna A, Shen W, Chi V, Cahalan MD. |
J Biol Chem. 2008 Jun 20;283(25):17662-71. doi: 10.1074/jbc.M801536200. Epub 2008 Apr 17. |
PMID 18420579 |
Genome-wide RNAi screen of Ca(2+) influx identifies genes that regulate Ca(2+) release-activated Ca(2+) channel activity. |
Zhang SL, Yeromin AV, Zhang XH, Yu Y, Safrina O, Penna A, Roos J, Stauderman KA, Cahalan MD. |
Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9357-62. Epub 2006 Jun 2. |
PMID 16751269 |
STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane. |
Zhang SL, Yu Y, Roos J, Kozak JA, Deerinck TJ, Ellisman MH, Stauderman KA, Cahalan MD. |
Nature. 2005 Oct 6;437(7060):902-5. |
PMID 16208375 |
Mechanisms of STIM1 activation of store-independent leukotriene C4-regulated Ca2+ channels. |
Zhang X, Gonzalez-Cobos JC, Schindl R, Muik M, Ruhle B, Motiani RK, Bisaillon JM, Zhang W, Fahrner M, Barroso M, Matrougui K, Romanin C, Trebak M. |
Mol Cell Biol. 2013 Sep;33(18):3715-23. doi: 10.1128/MCB.00554-13. Epub 2013 Jul 22. |
PMID 23878392 |
Potent inhibition of Ca2+ release-activated Ca2+ channels and T-lymphocyte activation by the pyrazole derivative BTP2. |
Zitt C, Strauss B, Schwarz EC, Spaeth N, Rast G, Hatzelmann A, Hoth M. |
J Biol Chem. 2004 Mar 26;279(13):12427-37. Epub 2004 Jan 12. |
PMID 14718545 |
Citation |
This paper should be referenced as such : |
J Hasna, N Benzerdjeb, M Faouzi, AS Ay, P Kischel, F Hague, H Sevestre, A Ahidouch, H Ouadid-Ahidouch |
ORAI3 (ORAI calcium release-activated calcium modulator 3) |
Atlas Genet Cytogenet Oncol Haematol. 2015;19(3):176-188. |
Free journal version : [ pdf ] [ DOI ] |
On line version : http://AtlasGeneticsOncology.org/Genes/ORAI3ID51589ch16p11.html |
External links |
REVIEW articles | automatic search in PubMed |
Last year publications | automatic search in PubMed |
© Atlas of Genetics and Cytogenetics in Oncology and Haematology | indexed on : Wed Nov 13 21:45:37 CET 2019 |
For comments and suggestions or contributions, please contact us